FDA halts marketing of unapproved colchicine - ONA
Links shared publicly online about this topic.
- 833total visits
FDA halts marketing of unapproved colchicine - ONA
View full resource at oncologynurseadvisor.com
Tags: FDA
Most Recently Shared on October 1, 2010 at 3:04 pm By:
FDA halts marketing of unapproved colchicine http://goo.gl/fb/qkw7J
NMQF CEO Applauds FDA For Removing Unapproved Colchicine From Market
medicalnewstoday.com — “Gary Puckrein, President and CEO of the National Minority Quality Forum (The Forum), recently spoke out in support” View full resource at medicalnewstoday.com
Most Recently Shared on October 15, 2010 at 2:05 pm By:
NMQF CEO Applauds FDA For Removing Unapproved Colchicine From Market http://mnt.to/3LfH #pharmacy #pharmacist
NMQF CEO Applauds FDA For Removing Unapproved Colchicine From Market - QualityPoint Technologies
qualitypointtech.net — “Gary Puckrein, President and CEO of the National Minority Quality Forum (The Forum), recently spoke out in support of the Food and Drug Administration's (FDA) actions taken to remove unapproved colchicine products from the marketplace.” View full resource at qualitypointtech.net
Most Recently Shared on October 15, 2010 at 1:25 pm By:
NMQF CEO Applauds FDA For Removing Unapproved Colchicine From Market: Gary Puckrein, President and CEO of the Nati... http://bit.ly/9MPeK4
NursingCenter
nursingcenter.com — “. NursingCenter.com... Over 900 CE activities and thousands of clinical articles from over 50 leading Lippincott Williams & Wilkins nursing journals, including: The American Journal of Nursing, Nursing2007, Nursing Management, The Nurse Practitioner, Nursing Made Incredibly Easy, and many more specialty journals.” View full resource at nursingcenter.com
Most Recently Shared on October 3, 2010 at 11:50 am By:
Lisa Morris Bonsall Nurse and Advanced Practice Nurse
FDA Calls for Halt on Marketing of Unapproved Colchicine http://bit.ly/9KTtPD
FDA Bans Marketing of Unapproved Forms of Colchicine : Skin & Allergy News
skinandallergynews.com — “Skin & Allergy News Digital Network is the online destination and multimedia properties of Skin & Allergy News, the independent news publication for the dermatology community. Our breaking news covers all areas of medical dermatology, dermatologic surgery, and aesthetic dermatology. We also provide the news by specialty interest: acne and rosacea, atopic dermatitis and eczema, cutaneous oncology, hair and nails, infectious diseases, pediatric dermatology, psoriasis and rheumatologic disorders, s” View full resource at skinandallergynews.com
Most Recently Shared on October 1, 2010 at 3:33 pm By:
Skin & Allergy News Health News
FDA Bans Marketing of Unapproved Forms of Colchicine (gout drug) http://bit.ly/9vh6yh
FDA halts marketing of unapproved colchicine - MPR
empr.com — “The FDA has informed companies that manufacture, distribute, and/or market unapproved single-ingredient oral colchicine that they are expected to stop manufacturing single-ingredient oral colchicine within 45 days and must stop shipping this unapproved product in interstate commerce within 90 days.” View full resource at empr.com
Most Recently Shared on October 1, 2010 at 3:20 pm By:
MPR News: FDA halts marketing of unapproved colchicine: The FDA has informed companies that manufacture, distribut... http://bit.ly/bPH8tn
FDA bans unapproved gout treatments - FiercePharma
fiercepharma.com — “FDA announced plans to ban unapproved gout treatments, favoring Mutual Pharmaceuticals' new version of the decades-old product, Colcrys. Hikma Pharma, which markets old-time colchicine, says its... Read more...” View full resource at fiercepharma.com
Most Recently Shared on October 1, 2010 at 2:20 pm By:
FDA bans unapproved gout treatments. http://bit.ly/arDl4Y
FDA Orders Halt to Marketing of Unapproved Single-ingredient Oral Colchicine - Drugs.com MedNews
drugs.com — “Drug commonly used to prevent gout, treat gout flares, and treat Familial Mediterranean Fever (FMF) The U.S. Food and Drug Administration today took action agai” View full resource at drugs.com
Most Recently Shared on October 1, 2010 at 12:18 pm By:
Drugs and Devices OW OW Health
FDA Orders Halt to Marketing of Unapproved Single-ingredient Oral Colchicine: Drug commonly used to prevent g... http://bit.ly/aGD2VH #drug
FDA Orders Halt to Marketing of Unapproved Single-Ingredient Oral Colchicine - QualityPoint Technologies
qualitypointtech.net — “Source: Food and Drug Administration Related MedlinePlus Pages: Fever, Gout (Source: MedlinePlus Health News)” View full resource at qualitypointtech.net
Most Recently Shared on October 1, 2010 at 6:36 am By:
FDA Orders Halt to Marketing of Unapproved Single-Ingredient Oral Colchicine: Source: Food and Drug Administration... http://bit.ly/aaJkAq
FDA Orders Most Colchicine Products Off the Market - QualityPoint Technologies
qualitypointtech.net — “WASHINGTON (MedPage Today) -- The FDA has warned manufacturers, marketers, and distributors of single-ingredient oral colchicine products to stop distribution of the unapproved drugs.” View full resource at qualitypointtech.net
Most Recently Shared on September 30, 2010 at 9:12 pm By:
FDA Orders Most Colchicine Products Off the Market: WASHINGTON (MedPage Today) -- The FDA has warned manufacturers... http://bit.ly/9ADrAx
FDA Orders Halt to Marketing of Unapproved Single-Ingredient Oral Colchicine
fda.gov — “The U.S. Food and Drug Administration today took action against companies that manufacture, distribute, and/or market unapproved single-ingredient oral colchicine, a medication commonly used for the daily prevention of gout, to treat acute gout flare-ups, and for the treatment of Familial Mediterranean Fever (FMF).” View full resource at fda.gov
Most Recently Shared on September 30, 2010 at 6:55 pm By:
eyeonfda Health Lawyer and Pharma
RT @FDA_Drug_Info: FDA orders halt to marketing of unapproved single-ingredient oral colchicine. http://bit.ly/oralcolchicine
Autism treatment: Dietary supplement OSR#1 pulled off shelves after FDA warning - chicagotribune.com
chicagotribune.com — “Pharmacies are pulling the dietary supplement OSR#1 off their shelves six weeks after the FDA called the product an unapproved new drug. The compound has been marketed to parents of children with autism.” View full resource at chicagotribune.com
Most Recently Shared on July 26, 2010 at 11:02 pm By:
Peter H Brown Doctor and Psychologist
Controversial supplement to come off shelves http://bit.ly/9Hq0US #autism
FDA Acts To Halt Marketing Of Unapproved Codeine Sulfate Tablets
medicalnewstoday.com — “The U.S. Food and Drug Administration warned four companies that they must stop marketing unapproved codeine sulfate tablets. These drugs are opioid analgesics, commonly called narcotics, that are” View full resource at medicalnewstoday.com
Most Recently Shared on October 14, 2009 at 1:40 pm By:
MNT Pain News Health News and Pain Management
FDA Acts To Halt Marketing Of Unapproved Codeine Sulfate Tablets: The U.S. Food and Drug Administration warned .. http://bit.ly/3rdVcM
FDA Acts to Halt Marketing of Unapproved Codeine Sulfate Tablets
fda.gov — “The U.S. Food and Drug Administration today warned four companies that they must stop marketing unapproved codeine sulfate tablets. These drugs are opioid analgesics, commonly called narcotics, that are widely used to treat pain.” View full resource at fda.gov
Most Recently Shared on October 13, 2009 at 6:08 pm By:
eyeonfda Health Lawyer and Pharma
FDA Acts to Halt Marketing of Unapproved Codeine Sulfate Tablets http://bit.ly/9SeQ6
FDA halts marketing of unapproved prescription narcotics - MPR
empr.com — “The FDA has warned nine companies to stop manufacturing and distributing 14 unapproved narcotic drugs that are marketed in several dosage forms and are widely used to treat pain.” View full resource at empr.com
Most Recently Shared on April 1, 2009 at 9:30 pm By:
MPR News: FDA halts marketing of unapproved prescription narcotics: The FDA has warned nine companies t.. http://tinyurl.com/cmn78p
Advertisement
